SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus

Published:2023-05-11 Issue:1 Volume:24 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Geng Wenwen¹²,Cao Meiling³,Dong Ke¹,An Junhua¹,Gao Haidong¹²^ORCID

Affiliation:

1. Department of Breast Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China

2. Oncology Laboratory, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China

3. Department of Rheumatology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China

Funder

Natural Science Foundation of Shandong Province

Qilu Hospital of Shandong University

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2206362

Reference24 articles.

1. Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

2. Comprehensive molecular portraits of human breast tumours

3. PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment

4. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

5. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and verification of a nomogram to predict risk and prognostic factors of triple-negative breast cancer with organ metastasis based on the SEER cohort study;2023-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3